Table 3 Erythropoiesis-stimulating agent type and frequency at month 12 for peritoneal dialysis patients who initiated darbepoetin alfa Q2W treatment
From: Extended dosing of darbepoetin alfa in peritoneal dialysis patients
Frequency | ESA Type (n = 616) | ||
|---|---|---|---|
Darbepoetin alfa n (%) | Epoetin alfa n (%) | Epoetin beta n (%) | |
Total | 594 (96.4%) | 13 (2.1%) | 9 (1.5%) |
TIW/BIW | 5 (0.8%) | 5 (0.8%) | 2 (0.3%) |
QW | 94 (15.3%) | 3 (0.5%) | 4 (0.6%) |
Q2W | 431 (70.0%) | -- | -- |
QM | 34 (5.5%) | -- | -- |
Other | 30 (4.9%) | 5 (0.8%) | 3 (0.5%) |